• Service Utilization Patterns and Direct Medical Costs of Hospitalization in Patients With Renal Failure Before and After Initiating Home Peritoneal Dialysis

    May 1, 2024, 00:00

  • The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand [Editor's Choice]

    May 1, 2024, 00:00

  • A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia [Editor's Choice]

    May 1, 2024, 00:00

  • Impact of Lung Cancer on Health-Related Quality of Life, Financial Toxicity, and Household Economics in Patients From the Public and the Private Healthcare Sector in Argentina [Editor's Choice]

    May 1, 2024, 00:00

  • Analysis of Health-Related Quality of Life and Incurred Costs Among Human Immunodeficiency Virus, Tuberculosis, and Tuberculosis/HIV Coinfected Outpatients in Indonesia

    May 1, 2024, 00:00

  • Quality of Life of Patients With Cancer at the Beni Mellal Oncology Center

    May 1, 2024, 00:00

  • Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan

    Mar 1, 2024, 00:00

  • Cost-Utility Model of Nirmatrelvir/Ritonavir in Brazil: Analysis of a Vaccinated Population [Editor's Choice]

    Mar 1, 2024, 00:00

  • Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia [Editor's Choice]

    Mar 1, 2024, 00:00

  • Cost-Utility Analysis of Continuous Positive Airway Pressure Therapy Compared With Usual Care for Obstructive Sleep Apnea in the Public Health System in Brazil

    Mar 1, 2024, 00:00

  • Cost-Effectiveness of Onasemnogene Abeparvovec Compared With Nusinersen and Risdiplam in Patients With Spinal Muscular Atrophy Type 1 in Brazil

    Mar 1, 2024, 00:00

  • The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment [Editor's Choice]

    Mar 1, 2024, 00:00

  • Comparative Analysis of the Healthcare Delivery System in China and Nigeria: A Review

    Mar 1, 2024, 00:00

  • Evolving Trends and Economic Burden of Benzodiazepine Use: Insights From a 10-Year Predictive Model

    Mar 1, 2024, 00:00

  • Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure

    Mar 1, 2024, 00:00

  • The Urban-Rural Difference in Child Mental Health in Vietnam: The Continuing Impacts of the COVID-19 Pandemic on Health

    Mar 1, 2024, 00:00

  • Automated Peritoneal Dialysis With Remote Patient Monitoring: Clinical Effects and Economic Consequences for Poland

    Mar 1, 2024, 00:00

  • Multivariate Relationships Between Health Outcomes and Health System Performance Indicators: An Integrated Factor Analysis With Canonical Correlations [Editor's Choice]

    Mar 1, 2024, 00:00

  • Editorial Board

    Mar 1, 2024, 00:00

  • Economic Burden of Alzheimer’s Disease: A Systematic Review

    Mar 1, 2024, 00:00

  • Costs of Receiving Developmental Services for Children With Global Developmental Delay at Siriraj Hospital in Bangkok, Thailand

    Mar 1, 2024, 00:00

  • A Vulnerability Index for Mitigation and Prevention of Diabetes Growth in India: A Disaggregated Analysis [Editor's Choice]

    Mar 1, 2024, 00:00

  • Table of Contents

    Feb 26, 2024, 08:36

  • Copyright/Subscription

    Jan 12, 2024, 10:29

  • Editorial Board

    Jan 1, 2024, 00:00

  • Forging Partnership Between Health Economics Researchers and Policy Makers: Better Methods, Better Policy, Better Health

    Jan 1, 2024, 00:00

  • Decision-Utility Analysis of Empiric Treatment Versus Test and Treat Strategies for Helicobacter pylori in Patients With Duodenal Ulcer

    Jan 1, 2024, 00:00

  • Scoping Review of Health Economics Research on Refugee Health in Sub-Saharan Africa

    Jan 1, 2024, 00:00

  • Study of the Direct Costs of Asthma at a Healthcare Service Provider in Bogotá, Colombia

    Jan 1, 2024, 00:00

  • Breast Cancer Screening in Georgia: Choosing the Most Optimal and Cost-Effective Strategy

    Jan 1, 2024, 00:00

  • Looking to the Future: A Vision for Value in Health Regional Issues

    Jan 1, 2024, 00:00

  • Economical Evaluation of Prostate Cancer Treatment Using Intensity-Modulated Radiation Therapy, 3-Dimensional Conformal Radiation Therapy and Radical Prostatectomy: A Systematic Review

    Jan 1, 2024, 00:00

  • Revision of Malawi’s Health Benefits Package: A Critical Analysis of Policy Formulation and Implementation [Editor's Choice]

    Jan 1, 2024, 00:00

  • Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income Countries [Editor's Choice]

    Jan 1, 2024, 00:00

  • Adapting Economic Evaluation Methods to Shifting Global Health Priorities: Assessing the Value of Health System Inputs [Editor's Choice]

    Jan 1, 2024, 00:00

  • Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non–Small Cell Lung Cancer for the Colombian Health System [Editor's Choice]

    Jan 1, 2024, 00:00

  • Demands for Intersectoral Actions to Meet Health Challenges in East and Southern Africa and Methods for Their Evaluation

    Jan 1, 2024, 00:00

  • Table of Contents

    Jan 1, 2024, 00:00

  • Choosing the Best Instrument for Measuring Health Spillover Effect in Caregivers of Patients With Multiple Sclerosis [Editor's Choice]

    Jan 1, 2024, 00:00

  • Health System Financing and Resource Allocation in Humanitarian Settings: Toward a Collaborative Policy Research Agenda in the Eastern Mediterranean Region

    Jan 1, 2024, 00:00

  • Research-to-Policy Partnerships for Evidence-Informed Resource Allocation in Health Systems in Africa: An Example Using the Thanzi Programme

    Jan 1, 2024, 00:00

  • The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

    Jan 1, 2024, 00:00

  • Central America and the Dominican Republic at Crossroads: The Importance of Regional Cooperation and Health Economic Research to Address Current Health Challenges

    Jan 1, 2024, 00:00

  • Copyright/Subscription

    Nov 13, 2023, 10:52

  • The Relationship Between the Health Transformation Program and Health Expenditures: Evidence From an Autoregressive Distributed Lag Testing Approach

    Nov 1, 2023, 00:00

  • Willingness to Pay for Colorectal Cancer Screening in Vietnam: Policy Implications From a Contingent Valuation Survey [Editor's Choice]

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Ibrutinib as First-line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Glucose-Lowering Therapies as Add-on to Standard Care for People With Type 2 Diabetes in Malaysia [Editor's Choice]

    Nov 1, 2023, 00:00

  • Integrating Noncancer Chronic Pain to Multimorbidity: A Real Practice Challenge in Chile

    Nov 1, 2023, 00:00

  • Table of Contents

    Nov 1, 2023, 00:00

  • Trajectories of Cancer Care in Latin America: A Scope Review

    Nov 1, 2023, 00:00

  • Should the Preference-Based Index Set of Values Be Country or Disease Specific? An Analysis Using Data From Women With Symptoms of Overactive Bladder

    Nov 1, 2023, 00:00

  • Home Gardening of Yellow Cassava and Orange Maize for the Prevention of Nutritional Blindness in Children: An Economic Evaluation and Value of Information Analysis

    Nov 1, 2023, 00:00

  • Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Hospice Palliative Care for Patients With Cancer and Family Caregivers: A Multicenter Study in Kazakhstan

    Nov 1, 2023, 00:00

  • Critical Analysis of Economic Evaluation of the Childhood Rotavirus Vaccination in Low- and Lower-Middle-Income Countries: A Systematic Review

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Osteoporosis Opportunistic Screening Using Computed Tomography in China [Editor's Choice]

    Nov 1, 2023, 00:00

  • Editorial Board

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia

    Nov 1, 2023, 00:00

  • The Cost-Effectiveness of Pertuzumab for the Treatment of Metastatic HER2+ Breast Cancer in Czechia: A Semi-Markov Model Using Cost States

    Nov 1, 2023, 00:00

  • Evaluation of a Transitional Care Strategy Implemented in Adults With High-Risk and Multimorbidity in Chile

    Nov 1, 2023, 00:00

  • Burden of COVID-19 in Córdoba, A Department of Colombia: Results of Disability-Adjusted Life-Years

    Sep 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer

    Sep 1, 2023, 00:00

  • Prioritizing Outcome Measures for Value-Based Healthcare: Physicians’ Perspectives in Saudi Arabia

    Sep 1, 2023, 00:00

  • Real-World Costs and Cost-Effectiveness Analysis of Rabbit-Antithymocyte Globulin Versus Oxymetholone in Acquired Aplastic Anemia in Thailand

    Sep 1, 2023, 00:00

  • Sensitivity Analysis in Economic Evaluations of Immuno-Oncology Drugs: A Systematic Literature Review

    Sep 1, 2023, 00:00

  • Factors Affecting Inequality in the Quality Diets: A Scoping Review

    Sep 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Relmacabtagene Autoleucel for Relapsed or Refractory Large B-Cell Lymphoma in China

    Sep 1, 2023, 00:00

  • The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi

    Sep 1, 2023, 00:00

  • Table of Contents

    Sep 1, 2023, 00:00

  • The Triglycerides and Glucose Index: A Cost-Effectiveness Analysis Compared With the Homeostatic Model Assessment for Insulin Resistance

    Sep 1, 2023, 00:00

  • Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study [Editor's Choice]

    Sep 1, 2023, 00:00

  • Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis

    Sep 1, 2023, 00:00

  • Editorial Board

    Sep 1, 2023, 00:00

  • Instructions for Authors

    Sep 1, 2023, 00:00

  • The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa [Editor's Choice]

    Sep 1, 2023, 00:00

  • Exploring the COVID-19 Pandemic’s Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System [Editor's Choice]

    Sep 1, 2023, 00:00

  • Eficácia E Custo-Utilidade De Intervenções Para O Tratamento Da Enurese Em Crianças E Adolescentes Sob A Perspectiva Do Sistema Único De Saúde Brasileiro

    Sep 1, 2023, 00:00

  • Assessment of Health-Related Quality of Life Using EQ-5D-5L Tool With Indian Tariffs Among Reproductive Age Group Women Living With HIV in India [Editor's Choice]

    Sep 1, 2023, 00:00

  • Copyright/Subscription

    Aug 25, 2023, 08:58

  • The Use of Economic Evaluation Tools in Essential Health Benefits Package Selection for Universal Health Coverage

    Jul 1, 2023, 00:00

  • Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in a Real-World Setting in Taiwan

    Jul 1, 2023, 00:00

  • Time From Marketing Authorization to Reimbursement of Medicines in Greece After the Introduction of the Health Technology Assessment Process From July 2018 to April 2022

    Jul 1, 2023, 00:00

  • Budget Impact Analysis of Utilization of Sacubitril/Valsartan for the Treatment of Heart Failure With Reduced Ejection Fraction in the Philippines

    Jul 1, 2023, 00:00

  • Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis

    Jul 1, 2023, 00:00

  • Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece [Editor's choice]

    Jul 1, 2023, 00:00

  • Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies? [Editor's Choice]

    Jul 1, 2023, 00:00

  • Table of Contents

    Jul 1, 2023, 00:00

  • Editorial Board

    Jul 1, 2023, 00:00

  • Healthcare Resource Utilization in Controlled Versus Uncontrolled Adults Living With Type 1 Diabetes in the South African Public Healthcare Sector [Editor's Choice]

    Jul 1, 2023, 00:00

  • Cost of Illness in Patients With COVID-19 Admitted in Three Brazilian Public Hospitals [Editor's Choice]

    Jul 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using a Semi-Markovian Model Approach in R

    Jul 1, 2023, 00:00

  • Cost-Utility Analysis Comparing Ocrelizumab Versus Rituximab in the Treatment of Relapsing-Remitting Multiple Sclerosis: The Colombian Perspective

    Jul 1, 2023, 00:00

  • Loss of Health State Utilities Attributable to Obesity [Editor's choice]

    Jul 1, 2023, 00:00

  • Real-World Populational-Based Quality of Life and Functional Status After Stroke

    Jul 1, 2023, 00:00

  • Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong

    Jul 1, 2023, 00:00

  • Copyright/Subscription

    Jun 14, 2023, 08:36

  • Copyright/Subscription

    May 2, 2023, 08:59

  • Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial [Editor's Choice]

    May 1, 2023, 00:00

  • Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses [Editor's Choice]

    May 1, 2023, 00:00

  • Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study

    May 1, 2023, 00:00

  • Willingness to Pay for Clinical Pharmacy Services Among People With Diabetes in Nigerian Community Pharmacies

    May 1, 2023, 00:00

  • Medication Use Questionnaire for Older Adults in Malaysia: Translation, Cultural Adaptation, and Reliability

    May 1, 2023, 00:00

  • Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile

    May 1, 2023, 00:00

  • An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom

    May 1, 2023, 00:00

  • The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia

    May 1, 2023, 00:00

  • Budget Impact Analysis of Comprehensive Genomic Profiling in Advanced Non–Small Cell Lung Cancer in Taiwan

    May 1, 2023, 00:00

  • Table of Contents

    May 1, 2023, 00:00

  • Reviewer Acknowledgment 2022

    May 1, 2023, 00:00

  • The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis

    May 1, 2023, 00:00

  • Exploring the Potential Challenges for Developing Generic Orphan Drugs for Rare Diseases: A Survey of US and European Markets [Editor's Choice]

    May 1, 2023, 00:00

  • Editorial Board

    May 1, 2023, 00:00

  • Cost-Effectiveness of Breast Cancer Early Detection Program in Low- and Middle-Income Countries: A Systematic Review [Editor's Choice]

    May 1, 2023, 00:00

  • Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country

    May 1, 2023, 00:00

  • Cross-Cultural Adaptation and Validation of the EuroQoL Toddler and Infant Populations Instrument Into Afrikaans for South Africa

    May 1, 2023, 00:00

  • Copyright/Subscription

    Mar 6, 2023, 08:17

  • Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran

    Mar 1, 2023, 00:00

  • Editorial Board

    Mar 1, 2023, 00:00

  • Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary [Editor's Choice]

    Mar 1, 2023, 00:00

  • Patient Access to Orphan Drugs Covered by Medical Insurance in China: Real-World Evidence From Patient Survey [Editor's Choice]

    Mar 1, 2023, 00:00

  • Supporting Decisions of the Brazilian Regulatory Agency for Supplementary Healthcare: A Case Study

    Mar 1, 2023, 00:00

  • Cost of Home-Based Couples Human Immunodeficiency Virus Counseling and Testing and Human Immunodeficiency Virus Self-Testing During Pregnancy and Postpartum in Southwestern Kenya

    Mar 1, 2023, 00:00

  • Economic Impact Analysis of Incorporation of Elecsys sFlt-1/PlGF Ratio Into Routine Practice for the Diagnosis and Follow-Up of Pregnant Women With Suspected Preeclampsia in Argentina

    Mar 1, 2023, 00:00

  • Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand

    Mar 1, 2023, 00:00

  • Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis [Editor's Choice]

    Mar 1, 2023, 00:00

  • Cost Analysis of Hospitalization for COVID-19 in a Brazilian Public Teaching Hospital

    Mar 1, 2023, 00:00

  • Table of Contents

    Mar 1, 2023, 00:00

  • Economic Evaluation of Selected Interleukin Inhibitors Versus Methotrexate for Moderate-to-Severe Plaque Psoriasis From the Philippine Payer Perspective

    Mar 1, 2023, 00:00

  • Budget Impact Analysis of Nusinersen for Spinal Muscular Atrophy in China

    Mar 1, 2023, 00:00

  • Cost-Effectiveness of Empagliflozin on Top of Standard of Care for Heart Failure With Reduced Ejection Fraction in Singapore

    Mar 1, 2023, 00:00

  • Current Medical Technology Reimbursement System in Japan [Editor's Choice]

    Mar 1, 2023, 00:00

  • The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa [Editor's Choice]

    Mar 1, 2023, 00:00

  • Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab

    Mar 1, 2023, 00:00

  • Patient-Reported Outcome Measures in Key Sub-Saharan African Languages to Promote Diversity: A Scoping Review

    Mar 1, 2023, 00:00

  • Crucial Business Model Elements for Medical Device Startup Companies in Emerging Markets

    Jan 1, 2023, 00:00

  • Editorial Board

    Jan 1, 2023, 00:00

  • Copyright/Subscription

    Jan 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Tobacco Control Strategies in Indonesia [Editor's Choice]

    Jan 1, 2023, 00:00

  • Revisando Conceptos de Acceso, Trayectorias, Participación y Conocimiento Tácito en Investigaciones Sobre Pacientes y Cobertura en Salud

    Jan 1, 2023, 00:00

  • Estimating Societal Cost of Illness and Patients’ Quality of Life of Duchenne Muscular Dystrophy in Egypt

    Jan 1, 2023, 00:00

  • Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations [Editor's Choice]

    Jan 1, 2023, 00:00

  • Clinical Outcomes and Direct Medical Expenditures Associated With Intensive Care Unit Admission for Inpatients With COVID-19 in Jordan: A Retrospective Cohort Study

    Jan 1, 2023, 00:00

  • Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina

    Jan 1, 2023, 00:00

  • Table of Contents

    Jan 1, 2023, 00:00

  • Budget Impact Analysis of Empagliflozin in the Treatment of Patients With Type 2 Diabetes With Established Cardiovascular Disease in South Africa

    Jan 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer From the Brazilian Public System Perspective

    Jan 1, 2023, 00:00

  • Costs and Quality of Life in Patients With Systemic Arterial Hypertension in Slovenia

    Jan 1, 2023, 00:00

  • Cost-Utility of Immunosuppressive Therapy Post-Renal Transplantation in Saudi Arabia: The Saudi Ministry of Health Perspective

    Jan 1, 2023, 00:00

  • Cost of Lung Cancer: A Systematic Review

    Jan 1, 2023, 00:00

  • Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System [Editor's Choice]

    Jan 1, 2023, 00:00

  • The Social Economic Return of a Positive End-Expiratory Pressure–Based Lung Recruitment Clinical Trial Program in Patients With Acute Respiratory Distress Syndrome

    Jan 1, 2023, 00:00

  • Copyright/Subscription

    Nov 3, 2022, 11:46

  • Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia [Editor's Choice]

    Nov 1, 2022, 00:00

  • Cost-Effectiveness Analysis of Pertuzumab Plus Trastuzumab and Docetaxel Compared With Trastuzumab and Docetaxel in the Adjuvant Treatment of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer in Colombia

    Nov 1, 2022, 00:00

  • Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study [Editor's Choice]

    Nov 1, 2022, 00:00

  • Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living With Human Immunodeficiency Virus: A Scoping Review

    Nov 1, 2022, 00:00

  • Validating the “Treatment Satisfaction Questionnaire for Medication” in Persian and Evaluating Treatment Satisfaction Among Patients With Psoriasis

    Nov 1, 2022, 00:00

  • Nutrition-Focused Care for Community-Living Adults: Healthcare Utilization and Economic Benefits

    Nov 1, 2022, 00:00

  • Reimbursement Savings Associated With Tissue Versus Mechanical Surgical Aortic Valve Replacement in Thailand

    Nov 1, 2022, 00:00

  • Editorial Board

    Nov 1, 2022, 00:00

  • Changes in the Number of Physicians and Hospital Bed Capacity in Europe

    Nov 1, 2022, 00:00

  • Cost-Effectiveness of Dulaglutide Versus Liraglutide for Management of Type 2 Diabetes Mellitus in Iran

    Nov 1, 2022, 00:00

  • Table of Contents

    Nov 1, 2022, 00:00

  • Microcosting Study of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Prostate Cancer

    Nov 1, 2022, 00:00

  • Analisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto) [Editor's Choice]

    Nov 1, 2022, 00:00

  • Cost-Effectiveness Analysis of Inguinal Hernia Repair With Mesh Performed by Surgeons and Medical Doctors in Ghana

    Nov 1, 2022, 00:00

  • Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions

    Nov 1, 2022, 00:00

  • The Clinical and Economic Impact of a Nonavalent Versus Bivalent Human Papillomavirus National Vaccination Program in Taiwan [Editor's Choice]

    Nov 1, 2022, 00:00

  • Translation, Cross-Cultural Adaptation, and Validation of the Polish Version of the Dizziness Handicap Inventory

    Nov 1, 2022, 00:00

  • Direct Medical Costs and Healthcare Resource Utilization of Treating Patients With Two Clinical Subtypes of Axial Spondyloarthritis in Colombia

    Nov 1, 2022, 00:00

  • Editorial Board

    Sep 12, 2022, 09:00

  • Distributive Pattern of Health Services Utilization Under Public Health Reform and Promotion in Turkey

    Sep 1, 2022, 00:00

  • Guidelines for Utility Measurement for Economic Analysis: The Brazilian Policy [Editor's Choice]

    Sep 1, 2022, 00:00

  • Does Efficiency of Oral and Dental Health Centers Change by the Development Level of Regions?

    Sep 1, 2022, 00:00

  • Cost-Effectiveness of Drug-Coated Balloon Angioplasty Compared With Conventional Balloon Angioplasty for Arteriovenous Access Flow Dysfunction

    Sep 1, 2022, 00:00

  • Preferences for Disease-Modifying Therapies in Argentina: Cross-Sectional Conjoint Analysis of Patients and Neurologists

    Sep 1, 2022, 00:00

  • Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India

    Sep 1, 2022, 00:00

  • Temporal Trend in an Initial Treatment, Survival, and Medical Costs Among Patients With Lung Cancer Between 2013 and 2018 in Kyoto City, Japan

    Sep 1, 2022, 00:00

  • Criteria for New Vaccine Introduction in a National Expanded Program on Immunization: A Survey of Expanded Program on Immunization Managers

    Sep 1, 2022, 00:00

  • Thromboprophylaxis of Patients Submitted to Total Hip and Knee Arthroplasty: A Cost-Effectiveness Assessment From the Perspective of the Brazilian National Health System

    Sep 1, 2022, 00:00

  • Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan

    Sep 1, 2022, 00:00

  • The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the GLOBOCAN 2012 to 2018 Estimates [Editor's Choice]

    Sep 1, 2022, 00:00

  • Stakeholders’ Views on Patient Access Schemes in Malaysia

    Sep 1, 2022, 00:00

  • Incorporating Concern for Health Equity Into Resource Allocation Decisions: Development of a Tool and Population-Based Valuation for Uganda [Editor's Choice]

    Sep 1, 2022, 00:00

  • Direct Medical Cost of Pediatric Asthma in Jordan: A Cost-of-Illness Retrospective Cohort Study

    Sep 1, 2022, 00:00

  • Cost-Utility of the CDK 4/6 Inhibitors for Postmenopausal Women With Luminal Advanced Breast Cancer in Brazil

    Sep 1, 2022, 00:00

  • Detección de Nuevas Tecnologías Sanitarias Para Mejorar el Control Metabólico de Pacientes Con Diabetes Tipo 2 Atendidos en el Programa de Salud Cardiovascular de Chile

    Sep 1, 2022, 00:00

  • Psychometric Evaluation of the Mandarin HeartQoL Health-Related Quality of Life Questionnaire Among Patients With Ischemic Heart Disease in China

    Sep 1, 2022, 00:00

  • Copyright/Subscription

    Sep 1, 2022, 00:00

  • Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan

    Sep 1, 2022, 00:00

  • Telehealth Strategies to Support Referral Management to Secondary Care in Brazil: A Cost-Effectiveness Analysis

    Sep 1, 2022, 00:00

  • Return on Investment of 10-Valent Pneumococcal Conjugate Vaccine in Ecuador From 2010 to 2030 [Editor's Choice]

    Sep 1, 2022, 00:00

  • How Expensive Are Hospitalizations by COVID-19? Evidence From Colombia

    Sep 1, 2022, 00:00

  • Cost Utility of Vaccination Against COVID-19 in Brazil

    Sep 1, 2022, 00:00

  • Table of Contents

    Sep 1, 2022, 00:00

  • Editorial Board

    Jul 18, 2022, 08:56

  • Cost-Effectiveness of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy Versus Systematic Transrectal Ultrasound-Guided Biopsy for Prostate Cancer Diagnosis: A Systematic Review

    Jul 1, 2022, 00:00

  • Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project [Editor's Choice]

    Jul 1, 2022, 00:00

  • Análisis de Costo Efectividad del Contacto Piel a Piel al Nacimiento, Temprano vs Inmediato, en la Morbilidad Neonatal de Recién Nacidos de Bajo Riesgo

    Jul 1, 2022, 00:00

  • A Validation Study of the EQ-5D-5L and ICEpop Capability Measure for Older People Among Older Individuals With Depressive Symptoms in Brazil

    Jul 1, 2022, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »